Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Imaging MS from Shimadzu, Alzheimer's Markers from Proteome Sciences

Premium

Shimadzu this week announced the launch of its Imaging Mass Microscrope, iMScope, which combines optical microscopy and mass spectrometry in one instrument.

The device combines an optical microscope and hybrid ion trap time of flight mass spectrometer, allowing for observation of high resolution morphological images via microscopy and for identification and visualization of specific molecules via mass spec.

The device can visualize molecules with sub-cellular resolution, achieving resolution of 5 µm, and allows for analysis of living cells or tissue samples, the company said.


Proteome Sciences this week launched its Alzheimer's CSF 16-plex assay, a protein biomarker panel for simultaneously measuring 16 protein biomarkers in cerebrospinal fluid.

Using selected-reaction monitoring mass spec, the panel is intended for monitoring disease in Alzheimer's patients and could potentially be used as a diagnostic assay, the company said.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.